The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Biomerieux Inc. for the supply of 0017 "SUSEPTIBILITY CARDS" with a ceiling value of $867,621.50. The period of performance runs from October 1, 2020 through September 30, 2023. This requirement was not set aside for any small business category. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its specialized microbiological testing solutions to support infectious disease testing and pathogen detection across government healthcare operations. The contract was awarded under the preexisting solicitation for pathology laboratory testing equipment at Madigan Army Medical Center, which sought mass spectrometry, automated identification and antimicrobial susceptibility testing systems, nucleic acid extraction systems, and automated broth incubation and growth detection systems.